Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Overt versus covert treatment for pain, anxiety, and Parkinson's disease.

Colloca L, Lopiano L, Lanotte M, Benedetti F.

Lancet Neurol. 2004 Nov;3(11):679-84. Review.

PMID:
15488461
2.

Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience.

Carlino E, Pollo A, Benedetti F.

Curr Opin Anaesthesiol. 2011 Oct;24(5):540-4. doi: 10.1097/ACO.0b013e328349d0c2. Review.

3.

Psychosocial interventions for depression and anxiety in Parkinson's disease.

Yang S, Sajatovic M, Walter BL.

J Geriatr Psychiatry Neurol. 2012 Jun;25(2):113-21. doi: 10.1177/0891988712445096. Review.

PMID:
22689704
4.

Pain is common in Parkinson's disease.

Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M.

Clin Neurol Neurosurg. 2011 Jan;113(1):11-3. doi: 10.1016/j.clineuro.2010.07.024. Epub 2010 Aug 25.

PMID:
20800342
5.

Placebo effects in therapeutic outcomes.

Horin AP, Lee KM, Colloca L.

Curr Clin Pharmacol. 2014 May;9(2):116-22. Review.

PMID:
23343015
6.

[How to manage daytime sleepiness associated with Parkinson's disease].

De Cock VC, Dauvilliers Y.

Rev Neurol (Paris). 2010 Oct;166(10):793-9. doi: 10.1016/j.neurol.2010.07.015. Epub 2010 Sep 1. Review. French.

PMID:
20813386
7.

Clinical management of pain and fatigue in Parkinson's disease.

Del Sorbo F, Albanese A.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S233-6. doi: 10.1016/S1353-8020(11)70071-2. Review.

PMID:
22166444
8.

Psychosis, apathy, depression and anxiety in Parkinson's disease.

Gallagher DA, Schrag A.

Neurobiol Dis. 2012 Jun;46(3):581-9. doi: 10.1016/j.nbd.2011.12.041. Epub 2012 Jan 3. Review.

PMID:
22245219
9.

Treatment strategies for nonmotor manifestations of Parkinson's disease.

Reichmann H, Ziemssen T.

Expert Opin Pharmacother. 2009 Apr;10(5):773-84. doi: 10.1517/14656560902811605 . Review.

PMID:
19351227
10.

Psychiatric factors related to sexual functioning in patients with Parkinson's disease.

Kotková P, Weiss P.

Clin Neurol Neurosurg. 2013 Apr;115(4):419-24. doi: 10.1016/j.clineuro.2012.06.020. Epub 2012 Jul 23.

PMID:
22831909
11.

Illness beliefs and psychological outcome in people with Parkinson's disease.

Simpson J, Lekwuwa G, Crawford T.

Chronic Illn. 2013 Jun;9(2):165-76. doi: 10.1177/1742395313478219. Epub 2013 Apr 12.

PMID:
23585631
12.

Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries.

Fricchione G, Stefano GB.

Med Sci Monit. 2005 May;11(5):MS54-65. Epub 2005 Apr 28. Review.

PMID:
15874901
13.

Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region.

Lanotte M, Lopiano L, Torre E, Bergamasco B, Colloca L, Benedetti F.

Brain Behav Immun. 2005 Nov;19(6):500-9. Epub 2005 Aug 1.

PMID:
16055306
14.

Subthalamic deep brain stimulation versus best medical therapy for L-dopa responsive pain in Parkinson's disease.

Sürücü O, Baumann-Vogel H, Uhl M, Imbach LL, Baumann CR.

Pain. 2013 Aug;154(8):1477-9. doi: 10.1016/j.pain.2013.03.008. Epub 2013 Mar 14.

PMID:
23632230
15.

When words are painful: unraveling the mechanisms of the nocebo effect.

Benedetti F, Lanotte M, Lopiano L, Colloca L.

Neuroscience. 2007 Jun 29;147(2):260-71. Epub 2007 Mar 26. Review.

PMID:
17379417
16.

Non-motor symptoms of Parkinson's disease: diagnosis and management.

Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence.

Lancet Neurol. 2006 Mar;5(3):235-45. Review.

PMID:
16488379
17.

Mood and sleep in Parkinson's disease.

Borek LL, Kohn R, Friedman JH.

J Clin Psychiatry. 2006 Jun;67(6):958-63.

PMID:
16848656
18.

Management of Parkinson's disease a review of current and new therapies.

Mendis T, Suchowersky O, Lang A, Gauthier S.

Can J Neurol Sci. 1999 May;26(2):89-103. Review.

PMID:
10352867
19.

Fear of falling and falls in people with Parkinson's disease treated with deep brain stimulation in the subthalamic nuclei.

Nilsson MH, Rehncrona S, Jarnlo GB.

Acta Neurol Scand. 2011 Jun;123(6):424-9. doi: 10.1111/j.1600-0404.2010.01418.x. Epub 2010 Sep 29.

PMID:
21492098
20.

Anticholinergics for symptomatic management of Parkinson's disease.

Katzenschlager R, Sampaio C, Costa J, Lees A.

Cochrane Database Syst Rev. 2003;(2):CD003735. Review.

PMID:
12804486

Supplemental Content

Support Center